Evidence map›Paper›PMID 41760964›Full record

ArticleJournal of neurology2026

Autonomic dysfunction in patients with wild-type transthyretin amyloidosis.

Vera E A Kleinveld, Julia Wanschitz, Anna Hotter, Corinne G C Horlings, Fabian Leys, Maria Ungericht, Gerhard Pölzl, Roberta Granata, Alessandra Fanciulli, Wolfgang N Löscher

Abstract read
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vera E A KleinveldDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Julia WanschitzDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Anna HotterDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Corinne G C HorlingsDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Fabian LeysDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Maria UngerichtDepartment of Cardiology, Medical University of Innsbruck, Innsbruck, Austria.
Gerhard PölzlDepartment of Cardiology, Medical University of Innsbruck, Innsbruck, Austria.
Roberta GranataDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Alessandra FanciulliDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria. alessandra.fanciulli@i-med.ac.at.ORCID http://orcid.org/0000-0002-2854-4179
Wolfgang N LöscherDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Funding

Pfizer 69872853
6 · The paper itself

Abstract

backgroundAutonomic dysfunction is well recognized in hereditary transthyretin amyloidosis (ATTRv), but it has not been systematically studied in wild-type transthyretin amyloidosis (ATTRwt). Because ATTRwt primarily presents with cardiomyopathy, autonomic symptoms may mimic heart failure and lead to inappropriate treatment. Here we aimed to investigate the presence and extent of autonomic dysfunction in ATTRwt.

methodsIn ATTRwt patients and controls, we performed an extensive autonomic examination, including standardized questionnaires, passive and active orthostatic challenges, Valsalva maneuver, deep breathing and sudomotor assessment.

results20 ATTRwt patients and 20 controls were included. Composite Autonomic Symptom Score 31-scores were similar between the groups. Orthostatic challenges revealed impaired blood pressure (BP) and heart rate regulation in ATTRwt compared to controls (for passive orthostatic challenge: HR p = 0.001, systolic BP p = 0.010) and diastolic BP p = 0.006; for active orthostatic challenge: HR p = 0.001, systolic BP p = 0.002, diastolic BP p = 0.002). A lack of late phase 2 BP overshoot during Valsalva maneuver was observed in ATTRwt and Valsalva Ratio was pathological in 83% of ATTRwt versus 30% of controls (p = 0.020). The rate of pathological sweat tests did not differ between ATTRwt patients and controls.

conclusionsAutonomic symptoms in ATTRwt were infrequently reported. However, detailed assessment revealed cardiovascular autonomic dysfunction, which contributes to the overall clinical phenotype of ATTRwt.

Indexed as

Amyloid Neuropathies, FamilialAutonomic Nervous System DiseasesAgedBlood PressureFemaleHeart RateHumansMaleMiddle AgedValsalva ManeuverAutonomic dysfunctionAutonomic testingOrthostatic hypotensionTilt table testingTransthyretin amyloidosis

Identifiers

PMID41760964
PMCPMC12948895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.